CellGenic_logo
Provider Login
My Account
Become a Provider
CellGenic_logo

Tesamorelin: Benefits, Handling, and Quality Standards

Product Usage: This PRODUCT IS INTENDED AS A RESEARCH CHEMICAL ONLY. This designation allows the use of research chemicals strictly for in vitro testing and laboratory experimentation only. All product information available on this website is for educational purposes only. Bodily introduction of any kind into humans or animals is strictly forbidden by law. This product should only be handled by licensed, qualified professionals. This product is not a drug, food, or cosmetic and may not be misbranded, misused or mislabeled as a drug, food or cosmetic.

What Is Tesamorelin?

Tesamorelin is a synthetic analog of growth hormone-releasing hormone (GHRH), stabilized against the rapid enzymatic degradation that limits native GHRH. It is studied for its effect on the GH/IGF-1 axis and, in particular, on visceral adipose tissue research models.

Regulatory note: a tesamorelin-based product is approved under applicable regulatory frameworks in the United States for a specific indication — reduction of excess visceral abdominal fat in HIV-associated lipodystrophy — marketed under a specific brand name. That approval and indication belong to that branded product and do not extend to, or imply anything about, CellGenic’s research-grade tesamorelin, which is supplied strictly for laboratory research use only.

Benefits and Uses

Research interest in tesamorelin centers on:
  • Visceral adipose tissue research, the best-documented research application, established through placebo-controlled clinical trial work
  • GH/IGF-1 axis research, given tesamorelin’s mechanism as a stabilized GHRH analog
  • Metabolic-marker research, including studied effects on fasting glucose and HbA1c that warrant separate monitoring in any research protocol

How It Works

Tesamorelin binds the GHRH receptor on pituitary somatotrophs, stimulating a pulsatile pattern of growth hormone release consistent with endogenous GHRH signaling, rather than the flat elevation associated with exogenous GH administration. Its stabilization against rapid degradation is what distinguishes it from native GHRH in research use.

Handling

Standard peptide storage and reconstitution practices apply. A reconstitution reference tool is available to convert a target concentration into a working solution volume. Labs conducting research can use CellGenic’s calculator to calculate the corresponding reconstitution volume for a professionally determined research dose without needing an account.

Quality and Verification Standards

  • Certificate of Analysis (COA) confirming identity and purity per lot
  • HPLC purity data
  • Mycoplasma, sterility, and identity testing per lot
  • cGMP-aligned manufacturing documentation

Become a Provider

Full pricing, ordering, and batch-specific Certificates of Analysis are available exclusively to verified providers.

References:

  1. Current EGRIFTA SV prescribing information
  2. Current EGRIFTA WR prescribing information
  3. Falutz et al.: controlled tesamorelin trial in adults with HIV
  4. Pooled phase 3 analysis of visceral fat outcomes
  5. Tesamorelin liver-fat trial in adults with HIV and NAFLD
  6. WADA 2026 Prohibited List

FAQ

What is tesamorelin?
Tesamorelin is a synthetic analog of growth hormone-releasing hormone (GHRH) studied for its effects on the growth hormone (GH) and insulin-like growth factor-1 (IGF-1) axis. Research has also examined its relationship with visceral adipose tissue.
Tesamorelin binds to GHRH receptors on pituitary somatotrophs and stimulates growth hormone release. Its structure is designed to provide greater stability against enzymatic degradation than native GHRH.
Tesamorelin is primarily studied in research involving visceral adipose tissue, the GH/IGF-1 axis, and selected metabolic markers. Its research applications should be determined according to the objectives and methodology of the individual laboratory protocol.
No. CellGenic’s tesamorelin is supplied strictly as a research chemical for laboratory and in vitro research. It is not approved, marketed, or supplied by CellGenic as a drug, medical treatment, food, or cosmetic.
No. A tesamorelin-based product has received regulatory approval in the United States for a specific indication associated with HIV-related lipodystrophy. That approval applies to the specific approved drug product and does not extend to CellGenic’s research-grade tesamorelin

REGULATORY DISCLAIMER · PEPTIDES

These products are intended for laboratory research use only. They are not drugs, foods, cosmetics, or medical treatments and must not be used for any form of human or animal administration. All information provided is for educational and scientific reference only and the products should be handled exclusively by licensed, qualified professionals. Misbranding, misuse, or mislabeling of these products as therapeutic or consumable substances is strictly prohibited by law.

CellGenic ships exclusively to Mexico, Argentina, Colombia, and Perú under local license. Verified-provider-only platform from CellGenic.

Shopping cart0
There are no products in the cart!
Continue shopping
Cart Gated

Cart is provider-gated. Log in to view.

Provider Login →